The time dependent association of adrenaline administration and survival from out-of-hospital cardiac arrest  by Ewy, Gordon A. et al.
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Background:  Recommended  for  decades,  the  therapeutic  value  of  adrenaline  (epinephrine)  in  the  resus-
citation of patients  with  out-of-hospital  cardiac  arrest (OHCA)  is controversial.
Purpose:  To investigate  the  possible  time-dependent  outcomes  associated  with  adrenaline  administration
by  Emergency  Medical  Services  personnel  (EMS).
Methods:  A  retrospective  analysis  of  prospectively  collected  data  from  a  near  statewide  cardiac  resusci-
tation  database  between  1  January  2005  and  30 November  2013.  Multivariable  logistic  regression  was
used  to analyze  the  effect  of the  time  interval  between  EMS dispatch  and  the  initial  dose  of  adrenaline  on
survival.  The  primary  endpoints  were  survival  to hospital  discharge  and  favourable  neurologic  outcome.
Results:  Data  from  3469  patients  with witnessed  OHCA  were  analyzed.  Their  mean  age was  66.3  years  and
69%  were  male.  An initially  shockable  rhythm  was  present  in 41.8%  of patients.  Based  on  a multivariable
logistic  regression  model  with  initial  adrenaline  administration  time  interval  (AATI)  from  EMS  dispatch
as  the  covariate,  survival  was  greatest  when  adrenaline  was  administered  very  early  but  decreased
rapidly  with  increasing  (AATI);  odds  ratio 0.94 (95%  Conﬁdence  Interval  (CI)  0.92–0.97).  The  AATI had  no
signiﬁcant  effect  on  good  neurological  outcome  (OR  =  0.96,  95%  CI =  0.90–1.02).
Conclusions:  In  patients  with  OHCA,  survival  to  hospital  discharge  was  greater  in  those  treated  early  with
adrenaline  by  EMS  especially  in the subset  of patients  with  a shockable  rhythm.  However  survival  rapidly
decreased  with  increasing  adrenaline  administration  time  intervals  (AATI).
rs.  Pu©  2015  The  Autho
ntroduction
Out-of-hospital cardiac arrest (OHCA) continues to be a major
ublic health problem in industrialized nations, accounting for
he majority of deaths in adult males.1,2 In patients with OHCA,
he importance of early recognition, prompt initiation of chest
ompressions, early activation and arrival of emergency med-
cal services (EMS) personnel, and optimal post-resuscitation
n-hospital care are all well documented.
 A Spanish translated version of the summary of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2015.08.011.
∗ Corresponding author at: 932 West San Martin Drive, Tucson, AZ 85704, United
tates.
E-mail address: gaewy1933@gmail.com (G.A. Ewy).
ttp://dx.doi.org/10.1016/j.resuscitation.2015.08.011
300-9572/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).blished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Although recommended for nearly a century, over the past
decade, adrenaline’s (epinephrine’s) value, when administered by
EMS in the management of patients with OHCA, has been ques-
tioned. In animal studies, adrenaline’s effectiveness in ventricular
ﬁbrillation arrest is time-dependent. We  therefore hypothesized
that adrenaline’s impact on survival and neurological status, when
given to patients with OHCA arrest, would decrease with increas-
ing time intervals between EMS  dispatch and the time at which
the initial dose of adrenaline was administrated, the adrenaline
administration time interval (AATI).Methods
The purpose of this study was to assess the time-sensitive
effect of adrenaline when administered by EMS to patients with
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Fig. 1. A diagram of case analysis in the Save Hearts in Arizona Registry and Educa-
tional (SHARE) database of patients with out-of-hospital cardiac arrest (OHCA) used
to  select adult patients with witnessed cardiac arrest who received adrenaline byG.A. Ewy et al. / Resus
itnessed OHCA. We  evaluated survival and neurological status
f such patients in Arizona who received adrenaline by EMS  and
hose data were entered into the Save Hearts in Arizona Registry
nd Education (SHARE) database.3,4
opulation and emergency medical services
In 2010, Arizona had 6.4 million residents (http://quickfacts.
ensus.gov/qfd/states/04000.html), with 62-licensed acute care
ospitals. The Arizona Department of Health Services establishes
MS  protocols, but the scope of practice, provider certiﬁcation, EMS
rew conﬁguration, vehicle deployment, dispatch and response
ntervals, all vary somewhat across the state.5 In 2010, there were
9,428 licensed out-of-hospital providers statewide; Basic EMT
12,901], EMT-intermediate [99] and paramedics [6488]).5 One
undred and twenty EMS  agencies, responding to approximately
0% of the state’s population, participated in the state-sponsored
HARE Program.5 This program provided the data collection and
nfrastructure for this study and has been previously described in
etail.3–7 The vast majority of Arizona has an all ALS response,
hich means that while ﬁrst responders (e.g., law enforcement)
ay  begin CPR on scene as trained responders, the medical
esponders performing resuscitation are paramedics. In Arizona,
aramedics not only can, but also are encouraged to administer
drenaline for OHCA. A paramedic was involved in the resus-
itation effort in the vast majority of the patients. While some
roviders utilized automated time stamp technologies in their
onitor–deﬁbrillations to record drug delivery on their moni-
or/deﬁbrillators, others recorded the times manually or from
emory post-event. Emergency Medical Service data was obtained
rom the EMS patient care reports and the outcomes were obtained
ither directly from the hospitals or from the State Ofﬁce of Vital
ecords.3,5
Data collected from participating EMS  systems and hospitals are
anually entered into an Access 2007 (Microsoft, Redmond, WA)
atabase by an experienced team of trained data coordinators who
ink and abstract the information.5
ata analysis
Data from 1 January 2005 to 30 November 2013 in the SHARE
atabase were analyzed. There were 17,208 cases available for anal-
sis. Following the exclusion of paediatric patients (age less than
8 years), adults with “Do Not Resuscitate” documentation, EMS-
itnessed arrests, non-cardiac arrests, those not given adrenaline,
nd missing data for response variables, a total of 8629 adult
HCA of presumed cardiac aetiology who received adrenaline by
MS  were available for detailed analysis. Of these 3469 had a
itnessed OHCA and is the subset of patients herein analyzed
Fig. 1). The zero time for the adrenaline administration time inter-
al (AATI) was  taken as the time of EMS  dispatch as this was the
ost reliable time available. Variables included patient age, sex,
ystander CPR, the type of bystander CPR, the time interval from
ispatch to EMS arrival at scene, time between dispatch and the
nitial adrenaline administration time interval (AATI), initial EMS
lectrocardiographic rhythm, presence and number of deﬁbrilla-
ion shock(s), hospital survival and Cerebral Performance Category
CPC) score at hospital discharge (Tables 1 and 2).
The AATI, time interval from EMS  dispatch to the time that
drenaline, was ﬁrst administered, was calculated in patients in
hom both time intervals were available. Survival of patients to
ospital discharge are reported, using both the latest Utstein style
hat recommends reporting on all primary cardiac arrest and the
riginal Utstein style that recommended reporting arrests due to
hockable rhythms.8,9 In addition we report in this analysis, the per-
ent of survival of patients with favourable neurological outcomeEmergency Medical Services personnel (EMS).
[CPC 1 or 2] at the time of discharge, using the Glasgow-Pittsburg
CPC scale which has ﬁve categories: (1) Good cerebral performance;
(2) Moderate cerebral disability; (3) Severe cerebral disability; (4)
Coma or vegetative state; and (5) Death.10
Statistics
The primary outcomes for this study were survival to hospi-
tal discharge and survival with favourable neurological outcomes
among patients with witnesed OHCA. Descriptive statistics were
used to describe the study population and are reported frequency
as percent (%) or as means with standard deviations (SD). Logis-
tic regression was used to assess the association between the time
of adrenaline administration and outcomes and to study the dif-
ference between the adrenaline administration time-dependent
survival curves of those with an initially shockable or non-
shockable rhythm. We  adjusted for potential clustering effects
of EMS  agencies since patients treated by the same agency are
182 G.A. Ewy et al. / Resuscitation 96 (2015) 180–185
Table 1
Characteristics of the study population by EMS  initial rhythm.
Total cases
(N = 3469)
Shockable
rhythm
(n = 1451)
Non-shockable
rhythm
(n = 2018)
Male 2392 (69.0%) 1124 (77.5%) 1268 (62.8%)
Age, years (mean,
SD)
66.3 (15.1) 63.6 (14.5) 68.2 (15.2)
Bystander CPR
2/30 or unknown 1061 (30.6%) 459 (31.6%) 602 (29.8%)
CO-CPR 652 (18.8%) 345 (23.8%) 307 (15.2%)
Initial rhythm
VF/VT 1451 (41.8%) - –
Adrenaline
administration
time after
dispatch—Minutes
(mean, SD)
13.3 (5.8) 12.7 (5.4) 13.8 (6.0)
Dispatch to
arrival—minutes
(mean, SD)
5.6 (3.0) 5.3 (2.7) 5.8 (3.2)
Deﬁbrillation count
0 1637 (47.2%) 29 (2.0%) 1608 (79.7%)
1  488 (14.1%) 308 (21.2%) 180 (8.9%)
2–3  699 (20.1%) 529 (36.5%) 170 (8.4%)
4–5  426 (12.3%) 375 (25.8%) 51 (2.5%)
≥6  219 (6.3%) 210 (14.5%) 9 (0.4%)
Survival 405 (11.7%) 306 (21.1%) 99 (4.9%)
Intact neurological
survival
CPC scale 1 or 2 227 (6.5%) 189 (13.0%) 38 (1.9%)
CPC scale 3 or 4 94 (2.7%) 53 (3.7%) 41 (2.0%)
CPC scale
unknown
84 (2.4%) 64 (4.4%) 20 (1.0%)
SD = standard deviation; CPR = cardiopulmonary resuscitation; CO-CPR = chest
compression only CPR; VF/VT = ventricular ﬁbrillation/ventricular tachycardia;
CPC = cerebral performance category; CI = conﬁdence interval; EMS  = emergency
medical service personnel; AATI = adrenaline administration time interval (AATI).
Time in minutes from EMS  dispatch until ﬁrst dose of adrenaline was  administered
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Table 2
Multivariate logistic regression analysis: Factors associated with survival and intact
neurological survival.
Witnessed arrest (n = 3469) Survival Good neurological
outcome
OR  (95% CI) OR (95% CI)
Adrenaline administration
time after dispatch (main
effect)
0.95 (0.92, 0.97) 0.96 (0.90, 1.02)
Shockable rhythm: yes
(ref)
No 0.23 (0.15, 0.35) 0.29 (0.12, 0.71)
Adrenaline administration
time after dispatch and
Initial rhythm
(interaction effect)
AATI when rhythm is
shockable
0.94 (0.91, 0.97) 0.98 (0.92, 1.04)
AATI when rhythm is
non-shockable
0.95 (0.91, 1.00) 0.94 (0.84, 1.06)
Dispatch to arrival time 0.96 (0.91, 1.01) 0.93 (0.82, 1.06)
Gender: male (ref)
Female 1.27 (0.99, 1.63) 0.64 (0.36, 1.16)
Age: >80 years (ref)
18–40 vs >80 5.82 (3.42, 9.92) 1.94 (0.55, 6.88)
41–60 vs >80 3.16 (2.05, 4.87) 1.25 (0.44, 3.56)
60–80 vs >80 2.40 (1.57, 3.67) 1.59 (0.56, 4.52)
Bystander CPR: no
bystander CPR (ref)
Unknown or 2/30 1.03 (0.79, 1.34) 1.09 (0.57, 2.10)
Compression only CPR 1.31 (0.99, 1.73) 0.92 (0.45, 1.88)
Year: 2011–2013 (ref)
2004–2007 0.51 (0.37, 0.70) 3.61 (1.39, 9.37)
2008–2010 0.99 (0.77, 1.28) 1.00 (0.55, 1.81)
Deﬁbrillation: performed
(ref)
Not performed 0.88 (0.57, 1.37) 0.95 (0.38, 2.41)y  EMS.
ore likely to have similar responses to each other relative to
ther EMS  agencies. A hierarichial generalized linear mixed mod-
ls (HGLMs) (Proc GLIMMIX, SAS, Version 9.3, SAS Institute, Cary
C) were used to explore the effects of, and to control for, clus-
ering by EMS  agency. The analysis included known independent
isk factors for OHCA survival and neurological outcomes as well as
otential confounders associated with the outcomes and AATI. Con-
ounders considered were time interval from dispatch to arrival,
ear of arrest, age, sex, bystander CPR, initial rhythm, and number
f deﬁbrillatory shocks.
esults
A total of 3469 adults (18 years of age or older) with witnessed
HCAs met  includion criteria (Fig. 1). The patients with OHCA who
eceived adrenaline by EMS  had a mean age of 66.3 years and 69%
ere male. An initial shockable rhythm [ventricular ﬁbrillation (VF)
r ventricular tachycardia (VT)] was present in 41.8%. Overall, 405
atients (11.7%) survived and 227 (6.5%) had a good neurological
utcome. In the subset of patients with a shockable rhythm, the sur-
ival with good neurological outcome was 13.0% (189) compared
o 1.9% (38) for those with initially non-shockable rhythms. The
haracteristics of the study population by rhythm are presented in
able 1.
Table 2 shows the hierachical logistic regression model (withMS agency as a random effect) evaluating the relationship
etween the survival probability and the AATI. The hierachical
ogistic regression model was also used to compare the rela-
ionship between shockable and non-shockable rhythms on AATI.After adjusting for potential confounders, every minute of delay
in the AATI was associated with signiﬁcantly decreased odds of
survival (adjusted odds ratio [aOR] 0.95; 95% conﬁdence interval
[CI] 0.92–0.97). The interaction effect between the AATI and ini-
tial rhythm showed signiﬁcantly decreased odds of survival with
every minute increase in the AATI among patients with an ini-
tially shockable rhythm (aOR 0.94, 95% CI 0.91–0.97); whereas the
AATI had no signiﬁcant effect on survival among patients with ini-
tially non-shockable rhythms (aOR 0.95, 95% CI 0.91–1.00). The
AATI was not associated with good neurological outcome (aOR 0.96,
95% CI 0.90–1.02), and the interaction effect between AATI and ini-
tial rhythm was also not signiﬁcant, (shockable rhythm, aOR 0.98,
95% CI 0.92–1.04; initially non-shockable rhythm, aOR 0.94, 95% CI
0.84–1.06).
The odds ratio for survival and good neurological outcomes in
those patients without a shockable rhythm was poor (survival aOR
0.23, 0.95% 0.15–0.35; Good neurological outcome aOR 0.29, 95%
CI 0.12–0.71) as compared to those with shockable rhythm. Those
with an initially non-shockable rhythm were less likely to survive.
Fig. 2 is a plot of the survival probability of all patients with
OHCA plotted against the ATTI in ﬁve minute intervals. Fig. 3 is
a plot of the survival probability curves of those with and with-
out an initially shockable rhythm, plotted against the AATI in ﬁve
minute intervals. In each ﬁgure the number of patients in each
time interval is indicated by a symbol. Based on a logistic regres-
sion model, the survival probability signiﬁcantly decreased with
increasing AATI (aOR 0.95; 95% CI 0.92–0.97). Based on a logis-
tic regression mode with an interaction effect between ATTI and
the patient’s initially shockable status, shockable patients consis-
tently had a survival probability signiﬁcantly higher than initially
non-shockable patients (P < 0.001).
G.A. Ewy et al. / Resuscitation 96 (2015) 180–185 183
Fig. 2. The percent of survival of all patients in this study with out-of-hospital car-
diac arrest (OHCA) plotted against the time from EMS  dispatch to the time adrenaline
was  ﬁrst administrated, e.g. the Adrenaline Administration Time Interval (AATI). The
shape of the symbols (upper right hand corner) indicates the number of patients rep-
resented by each symbol, during each time period (represented by the horizontal
line).  The line through each symbol represents the average number of patients in
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Fig. 3. The percent survival of patients with either an initially shockable rhythm
(solid black) and an initially non-shockable rhythm (gray), plotted against the time
from EMS  dispatch to the time adrenaline was  ﬁrst administrated, e.g. the Adrenaline
Administration Time Interval (AATI). The shape of the symbols (upper right hand
corner) indicates the number of patients represented by each symbol, during each
time period (represented by the horizontal line). Each symbol represents the average
number of patients in each ﬁve-minute period. The exception is the ﬁrst (0–5 min)hat ﬁve-minute period. Note: The exception is the ﬁrst symbol. Since no patient
eceived adrenaline with a AATI of 1 or 2 min, the horizontal line for the ﬁrst symbol
epresents survival of all study patients whose AATI was  3–5 min.
iscussion
The major ﬁnding of this analysis is the signiﬁcant association
etween the adrenaline administration time interval (AATI) by EMS
o adult patients with OHCA and survival. It conﬁrmed that survival
f patients with OHCA was aetiology (initially shockable vs. initially
on-shockable) sensitive. When measured as a continuous variable,
urvival and neurological outcome were best when adrenaline was
iven early.11,12
aboratory research supported adrenaline administration
Adrenaline has long been recommended for use during
dvanced Cardiac Life Support (ACLS), based predominantly on
nimal studies.13–15 Over a century ago, Crile and Dolley reported
hat adrenaline was necessary for resuscitation of animals with
sphyxia arrest.13 Nearly a half-century ago, Redding and Pearson’s
nimal research called attention to the necessity of adrenaline
or resuscitation after ten minutes of untreated VF arrest.14 The
ime-sensitive effectiveness of adrenaline was supported by subse-
uent animal studies and it continues to be the major vasopressor
dvocated for patients with OHCA receiving Emergency Cardiac
are (ECC) by EMS. A relatively recent study from our laboratory
howed the decreasing effectiveness of adrenaline over time in the
anagement of VF arrest.11 In that study, ACLS was  not initiated
ntil ten minutes after VF arrest. Swine were randomized to either
lacebo, early adrenaline (11 min  after induction of VF), or delayed
drenaline (19 min  of VF).11 The return of spontaneous circulation
ROSC) was uncommon without the administration of adrenaline,
nd none of the “no adrenaline” animals survived to 24-h. Survival
t 24 h was signiﬁcantly greater (P = 0.001) with either early or
elayed adrenaline than when placebo was given.11 A signiﬁcant
urvival beneﬁt was seen with early (intraosseous) compared to
elayed (intravenous) administration of adrenaline as well.11
While there is some question about the direct applicability
f animal work to humans in determining optimal resuscitationtime interval. Since no patient received adrenaline with a AATI of 1 or 2 min, the hor-
izontal line through the ﬁrst symbol represents survival of patients (either initially
shockable or initially non-shockable), whose AATI were 3–5 min.
management, it should be noted that the institution of the current
approach to OHCA in Arizona was the result of animal research.
These investigators wrote, “Minimally interrupted cardiac resusci-
tation (MICR), also referred to as Cardiocerebral resuscitation, is
a new approach to out-of-hospital cardiac arrest for emergency
medical services (EMS) personnel developed at the University
of Arizona Sarver Heart Center, and ﬁrst instituted in Tucson,
Arizona, in 2003.”6 “This approach is intended to minimize inter-
ruptions of chest compressions, provide immediate pre-shock
chest compressions for prolonged ventricular ﬁbrillation (VF),
delay or eliminate endotracheal intubation, minimize positive
pressure ventilations, and decrease the time interval to intravenous
epinephrine administration.”16–20
Adrenaline effectiveness questioned
The analysis, herein published, of the potential time-sensitive
role of adrenaline administered by EMS  in the SHARE database in
Arizona, was precipitated by the increasing number of publications
questioning the role of adrenaline in the therapy of patients with
OHCA.
Following a 2002 review of almost eleven thousand cases of
OHCA in Sweden, the authors’ reported that “neither in total nor
in any subgroup” was there any beneﬁcial effects of adrenaline.21
Ong and associates reported that they were unable to establish
a signiﬁcant survival beneﬁt with the introduction of intra-
venous adrenaline into an EMS  system.”22 Hagihara and associates
reported that while the “use of pre-hospital epinephrine was signif-
icantly associated with increased chance of return of spontaneous
circulation (ROSC) there was  a decreased chance of survival and
good functional outcomes one month after the event.”23 Stiell
and associates found no difference in survival after implementing
intravenous drug administration during OHCA.24 In a prospective,
randomized controlled trial of intravenous (IV) drug administra-
tion for out-of-hospital cardiac arrest, Olasveengen and associates
reported that patients who  received Advanced Cardiac Life Support
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ACLS) without intravenous drug administration had higher rates
f short-term survival with no statistically signiﬁcant improve-
ent in survival to hospital discharge, quality of CPR, or long-term
urvival.25 In a post-hoc analysis of this trial, looking at those who
id and did not receive adrenaline, Olasveengen and associates
ound that “receiving adrenaline was associated with short-term
urvival, but decreased survival to hospital discharge and survival
ith favorable neurological outcomes.”26 However in this study
he time of adrenaline administration was not reported. Glover
nd associates from the Resuscitation Outcomes Consortium (ROC)
eviewed their registry of over 264 EMS  agencies and reported that
here was an “inverse relationship between the administration” of
drenaline and survival to hospital discharge.27
Lin and associates published a systematic review and meta-
nalysis of randomized controlled trials of adrenaline for OHCA
nd concluded: “There was no beneﬁt of epinephrine in survival
o discharge or neurological outcomes.”28 Dumas and associates
ound, in a cohort of patients who achieved ROSC, that pre-
ospital adrenaline was consistently associated with a lower
hance of survival, an association that demonstrated a dose-effect
nd persisted despite post-resuscitation interventions.29 These
nvestigators also reported that adrenaline’s administration was
ssociated with worse survival and neurological outcome that was
ot improved by post-resuscitation hypothermia.29 Unfortunately,
hey did not report why one-fourth of their patients were not given
drenaline.29
When assessing the role of adrenaline administration to patients
ith OHCA, a concern is that if a patient responds to an initial
eﬁbrillation shock, epinephrine may  not be needed. Such patients
ill have a better prognosis than those who do not respond to
nitial deﬁbrillation and who may  therefore need adrenaline to
btain ROSC. Support for this concern included the fact that in
he report by Dumas and associates, those receiving adrenaline
ad less favorable prognostic characteristics; they were older, less
ikely to have a witnessed event, less likely to present with a
hockable rhythm, and more likely to have a longer duration of
esuscitation.30
The ﬁrst, and thus far the only published randomized double-
lind placebo controlled trial of adrenaline in patients with
HCA, by Jacobs and associates, reported that ROSC occurred in
.4% of patients receiving placebo and in 23.5% who  received
drenaline (OR = 3.4; 95% CI 2.0–5.6).31 Survival to hospital dis-
harge was 1.9% and 4.0% respectively of patients receiving placebo
r adrenaline (OR = 2.2; 95% CI 0.7–6.3). All but two patients
both in the adrenaline group) had a Cerebral Performance Cat-
gory (CPC) score of 1–2.31 Although patients who  received
drenaline had a signiﬁcantly improved likelihood of achieving
OSC, they had no statistically signiﬁcant improvement in the pri-
ary outcome of survival to hospital discharge. Unfortunately, in
his study the time of the administration of adrenaline was  not
nown.31
Hayashi et al. reported that, the effectiveness of adrenaline for
atients with OHCA depended on the time of its administration.
hey reported that when adrenaline was administered in the early
hase, there was an improvement in neurologic outcome from
HCA secondary to VF.32 However, in their study of 4174 patients,
nly 24.2% received adrenaline. From the time of the call, only 9
atients received adrenaline during the ﬁrst 11 min.32
Nakahara and associates reported that patients who received
arly (<10 min) adrenaline had signiﬁcantly higher rates of intact
eurologic survival (odds ratio [OR] = 1.39, 95% conﬁdence interval
CI] = 1.08 to 1.78) and any survival (OR = 1.73, 95% CI = 1.46 to 2.04)
han those who did not receive early adrenaline, after adjusting for
otential confounders.32
Adrenaline augments the arterial pressures produced by chest
ompressions during the “circulatory phase” of VF arrest and mayn 96 (2015) 180–185
result in an adequate coronary perfusion pressure; thereby improv-
ing the chances of resuscitating the heart and the likelihood of
obtaining a return of spontaneous circulation (ROSC). Adrenaline
is clearly not as effective in promoting successful resuscitation
or in acceptable post-resuscitation cerebral function when given
very late.33 Yet, in OHCA epinephrine it is often given late. The
dichotomy of the time of drug administration in animal studies
and in man  could well be one of the reasons adrenaline admin-
istration for patients with OHCA has been so controversial. The
time difference between clinical and animal studies was quan-
titated by Reynolds and associates, who reported that the mean
time to ﬁrst drug administration in animal studies was 9.5 min
compared to a mean of 19.4 min  (P < 0.001) in patients with
OHCA.34
Limitations
The major limitation of this study is that it was not a random-
ized controlled trial. Although we used a uniform data collection
procedure based on the Utstein-style guidelines for reporting car-
diac arrest, we  cannot exclude the possibility of other uncontrolled
confounders. The time intervals we used (the adrenaline adminis-
tration time interval) were measured from the time of EMS  dispatch
to the time of the initial administration of adrenaline by EMS. The
actual time intervals between the onset of the cardiac arrest, its
recognition, the delay between recognition and activation of EMS,
were not available. Since data collection for this study encompassed
over 150 distinct EMS  systems in Arizona, the methodology of col-
lected treatment times for epinephrine was not standardized, and
therefore its actual degree of accuracy is uncertain.
It is well known that survival of patients with cardiac arrest
decreases with increasing delays in therapy. It is possible that
the delay in administration of adrenaline, herein reported, is a
reﬂection of this phenomenon. However, as detailed in our dis-
cussion, the time sensitive effectiveness of adrenaline is strongly
supported in large animal studies from our and others laboratories.
Numerous animal studies were the basis for the new approaches to
resuscitation in Arizona advocated in the SHARE program that has
resulted in improved survival of patients with OHCA where insti-
tuted. The number of doses of adrenaline that each patient received
was not available. There were only 45 patients with an initially
non-shockable rhythm, with “AATI” that were within three to ﬁve
minutes, and 9 or 20% survived. In those with an initially shockable
rhythm, 26 patients received adrenaline within 3 to 5 min from
dispatch, and 11 or 42% survived. The small number of patients
with AATI less than 5 min  who received adrenaline is a limitation.
As with all such studies, the ascertainment bias of the data is a
potential limitation.
Conclusions
In patients with OHCA, the association between adrenaline
administration by EMS  and survival to hospital discharge appeared
greatest when the adrenaline was  given early by EMS  but rapidly
decreased with increasing time delays. The time of adrenaline
administration had no signiﬁcant effect on good neurological out-
come. The adrenaline administration time interval appears to be a
signiﬁcant confounder and should be controlled for in future ran-
domized studies assessing adrenaline’s efﬁcacy.
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